Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis

Fig. 4

Surface under the cumulative ranking curve (SUCRA) rankings and posterior estimates of treatment effect on clinical cure. Greater SUCRA value indicates higher probability of being the best treatment for improving clinical cure. Abbreviations: CAR carbapenem (imipenem or meropenem), COL colistin, CrI credible interval, FOS fosfomycin, GLY glycopeptide (vancomycin or teicoplanin), HD high-dose, IH inhaled, IV intravenous, RIF rifampin, SUL sulbactam, TIG tigecycline

Back to article page

Critical Care

ISSN: 1364-8535